The MuSiC package comprised our growing suite of cohort -
level mutation analysis tools for cancer.
Not exact matches
Analysis of genomic, epigenetic, and RNA sequencing data revealed that the combinations of
mutations that lowered the
levels of functioning BRCA1 and BRCA2 RNA — genes that produce the breast cancer tumor suppressor proteins — were associated with significantly better survival outcomes.
Validating this original concept, we previously demonstrated that PGD - derived hES cells and their derivatives, which express the causal
mutation implicated in the Myotonic Dystrophy type 1 (DM1), offer pertinent disease - cell models, applicable for a wide systemic mechanistic
analysis ranging from functional studies at the cellular
level to a large - scale drug screening.
Although their copy - number methods are based on «read» density, there are classes of
mutations that require
analysis at the
level of the read.
The genomic
analysis found that the
level of diversity between the four individuals amounted to approximately 2 million variable
mutations, which is roughly similar to overall diversity exhibited by other endangered carnivores.
Genetic
analysis revealed that German shepherds with certain
mutations in the PKP2 gene had a much higher risk of eczema, suggesting that low
levels of the plakophilin - 2 protein break down the skin barrier in dogs with the
mutation.